Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: Advancements in PBMC Isolation – Enhancing Throughput and Consistency in Research
Published on: July 19, 2024
Experimental reconstruction of historical WBC measuring procedure in 1986
V V Vasynenko1, O M Ivanova1, L O Lytvynets1
1State Institution National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Melnykov str., 53, Kyiv, 04050, Ukraine.
Objective:
Examination and experimental reconstruction of the historical WBC measuring procedure in 1986 and estimation of the minimum detectable activity (MDA) of those measurements.
Materials And Methods:
The SRP 68 01 gamma spectrometer with attached scintillation detector based on a NaI(Tl) O 30 x 25 mm2 crystal and NC 482 ВМ one channel spectrometer (Bicron Co.) with attached scintillation detector based on a NaI(Tl) O 52 x 52 mm2 crystal were used for the study. Protective chamber of the expert type whole body counter (WBC) and homogenous human body dummy phantoms filled with dry radioactive material were applied. Results of measurements on the WBC «Screener 3M» were retrieved from the Radiation Registry of the NRCRM. Dosimetry and mathematical methods were applied too.
Results And Conclusions:
The WBC measurement procedure was reconstructed using the examples tested in 1986 to assay the level of incorporated radioactive cesium in population of contaminated territories. MDA under the WBC measurements in 1986 was found being from 1.3 kBq per human body using the NC 482 ВМ one channel spectrom eter with attached scintillation detector based on a NaI(Tl) O 52 x 52 mm2 crystal up to 7.4 kBq per human body using the SRP 68 01 gamma radiometer radiometer with attached scintillation detector based on a NaI(Tl) O 30 x 25 mm2 crystal in adults under the 60 seconds measurement time. The respective values for adolescents and chil dren were within 0.8-5.6 kBq per body and 0.5-3.8 kBq per body.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
09:27Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020